152 related articles for article (PubMed ID: 94209)
1. Pruritus in polycythemia vera: treatment with aspirin and possibility of platelet involvement.
Fjellner B; Hägermark Ö
Acta Derm Venereol; 1979; 59(6):505-12. PubMed ID: 94209
[TBL] [Abstract][Full Text] [Related]
2. 47-Year-Old Man With Pruritus.
Reneau JC; Patnaik MM
Mayo Clin Proc; 2016 Feb; 91(2):241-5. PubMed ID: 26769185
[No Abstract] [Full Text] [Related]
3. ADP-induced platelet aggregation and thrombin generation are increased in Essential Thrombocythemia and Polycythemia Vera.
Panova-Noeva M; Marchetti M; Russo L; Tartari CJ; Leuzzi A; Finazzi G; Rambaldi A; ten Cate H; Falanga A
Thromb Res; 2013 Jul; 132(1):88-93. PubMed ID: 23735588
[TBL] [Abstract][Full Text] [Related]
4. Polycythemia vera and mesenteric arterial thrombosis. A disease association resulting from decreased platelet sensitivity to aspirin.
Myers TJ; Steinberg WM; Rickles FR
Arch Intern Med; 1979 Jun; 139(6):695-8. PubMed ID: 443976
[TBL] [Abstract][Full Text] [Related]
5. Skin mast cells in polycythaemia vera: relationship to the pathogenesis and treatment of pruritus.
Jackson N; Burt D; Crocker J; Boughton B
Br J Dermatol; 1987 Jan; 116(1):21-9. PubMed ID: 3814512
[TBL] [Abstract][Full Text] [Related]
6. Response to aspirin therapy in patients with myeloproliferative neoplasms depends on the platelet count.
Gremmel T; Gisslinger B; Gisslinger H; Panzer S
Transl Res; 2018 Oct; 200():35-42. PubMed ID: 30012347
[TBL] [Abstract][Full Text] [Related]
7. Polycythaemia rubra vera and water-induced pruritus: blood histamine levels and cutaneous fibrinolytic activity before and after water challenge.
Steinman HK; Kobza-Black A; Lotti TM; Brunetti L; Panconesi E; Greaves MW
Br J Dermatol; 1987 Mar; 116(3):329-33. PubMed ID: 3567071
[TBL] [Abstract][Full Text] [Related]
8. The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera.
Michiels JJ; Berneman Z; Schroyens W; Finazzi G; Budde U; van Vliet HH
Semin Thromb Hemost; 2006 Sep; 32(6):589-604. PubMed ID: 16977569
[TBL] [Abstract][Full Text] [Related]
9. Phosphatidylserine expression on the platelet membrane of patients with myeloproliferative disorders and its effect on platelet-dependent thrombin formation.
Presseizen K; Friedman Z; Shapiro H; Radnay J; Ellis MH
Clin Appl Thromb Hemost; 2002 Jan; 8(1):33-9. PubMed ID: 11991237
[TBL] [Abstract][Full Text] [Related]
10. Platelet function abnormalities in the myeloproliferative disorders.
Adams T; Schutz L; Goldberg L
Scand J Haematol; 1974; 13(3):215-24. PubMed ID: 4533155
[No Abstract] [Full Text] [Related]
11. Prostaglandin E2 potentiation of platelet aggregation induced by LASS endoperoxide: absent in storage pool disease, normal after aspirin ingestion.
Weiss HJ; Willis AL; Kuhn D; Brand H
Br J Haematol; 1976 Feb; 32(2):257-72. PubMed ID: 1247498
[TBL] [Abstract][Full Text] [Related]
12. [Clinical evaluation of the control of antiplatelet therapy through platelet aggregation rate on polycythemia vera associated with thrombocytosis and erythromelalgia].
Kurihara A; Kobayashi I; Tamura K
Rinsho Ketsueki; 1989 Jan; 30(1):99-104. PubMed ID: 2716205
[TBL] [Abstract][Full Text] [Related]
13. Adverse effects of antiaggregating platelet therapy in the treatment of polycythemia vera.
Tartaglia AP; Goldberg JD; Berk PD; Wasserman LR
Semin Hematol; 1986 Jul; 23(3):172-6. PubMed ID: 3749927
[No Abstract] [Full Text] [Related]
14. Experimental and clinical pruritus. Studies on some putative peripheral mediators. The influence of ultraviolet light and transcutaneous nerve stimulation.
Fjellner B
Acta Derm Venereol Suppl (Stockh); 1981; 97():1-34. PubMed ID: 6177180
[No Abstract] [Full Text] [Related]
15. Aquagenic pruritus in polycythemia vera: A cross-sectional study.
Lelonek E; Matusiak Ł; Wróbel T; Szepietowski JC
J Am Acad Dermatol; 2021 Jul; 85(1):211-213. PubMed ID: 29066270
[No Abstract] [Full Text] [Related]
16. Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: a distinct aspirin-responsive and coumadin-resistant arterial thrombophilia.
Michiels JJ; Berneman Z; Schroyens W; Koudstaal PJ; Lindemans J; Neumann HA; van Vliet HH
Platelets; 2006 Dec; 17(8):528-44. PubMed ID: 17127481
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of acylpyrin, curantyl and ticlid on some platelet functions in patients with polycythemia vera.
Indrák K; Kapustová M; Hrcková Y; Kubis M; Scudla V; Jezdinský J
Acta Univ Palacki Olomuc Fac Med; 1985; 111():331-52. PubMed ID: 2949515
[No Abstract] [Full Text] [Related]
18. European Collaboration on Low-dose Aspirin in Polycythemia Vera (ECLAP): a randomized trial.
Landolfi R; Marchioli R
Semin Thromb Hemost; 1997; 23(5):473-8. PubMed ID: 9387206
[TBL] [Abstract][Full Text] [Related]
19. Stimulus-specific defect in platelet aggregation in polycythemia vera.
Le Blanc K; Berg A; Palmblad J; Samuelsson J
Eur J Haematol; 1994 Sep; 53(3):145-9. PubMed ID: 7925857
[TBL] [Abstract][Full Text] [Related]
20. Aquagenic Pruritus in Polycythemia Vera: Clinical Characteristics.
Lelonek E; Matusiak Ł; Wróbel T; Szepietowski JC
Acta Derm Venereol; 2018 Apr; 98(5):496-500. PubMed ID: 29437189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
